Clini Vigil Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
About Clini Vigil Pharma Solutions
Clini Vigil Pharma Solutions Private Limited (CVPSPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 September 2019 (Five years and five months 15 days old ). Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Clini Vigil Pharma Solution Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jayachandra Atluri and Santhi Atluri serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100TG2019PTC135343
- Company No.
135343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Sep 2019
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Clini Vigil Pharma Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayachandra Atluri  | Director | 11-Sep-2019 | Current |
| Santhi Atluri | Director | 11-Sep-2019 | Current |
Financial Performance of Clini Vigil Pharma Solutions.
Clini Vigil Pharma Solutions Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Clini Vigil Pharma Solutions?
In 2020, Clini Vigil Pharma Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Axis Clinicals LimitedJayachandra Atluri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clini Vigil Pharma Solutions?
Unlock and access historical data on people associated with Clini Vigil Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clini Vigil Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clini Vigil Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.